Cetera Advisor Networks LLC Novo Cure LTD Transaction History

Cetera Advisor Networks LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 16, 2021	SELL	$116.17 - $194.55 $140,565 - $235,405	-1,210 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$130.4 - $225.58 $157,784 - $272,951	1,210 New	1,210 $268,000
Q1 2021 May 17, 2021	SELL	$124.11 - $190.17 $162,335 - $248,742	-1,308 Closed	0 $0
Q4 2020 Feb 17, 2021	BUY	$112.16 - $174.14 $146,705 - $227,775	1,308 New	1,308 $226,000
Q3 2020 Nov 13, 2020	SELL	$58.05 - $111.31 $26,412 - $50,646	-455 Closed	0 $0

Q2 2020 Aug 13, 2020	BUY	$57.2 - $74.41 $26,026 - $33,856	455 New	455 $27,000

277

73.2M

1.43M

832K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.76B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisor Networks LLC with notifications on news.